Back to search

Article

Bioprinting of Human Primary and iPSC-derived Islets with Retained and Comparable Functionality

2024-10-16

Abstract excerpt

Currently, Type 1 diabetes (T1D) can be treated through implantation of allogenic islets, which replenish the beta cell population, however this method requires an extensive post-implantation immunosuppressant regimen. Personalized cellular therapy can address this through implantation of an autologous cell population, induced pluripotent stem cells (iPSCs). Cellular therapy, however, requires an encapsulation dev...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
13fc0b9e-fd78-5cbe-a2b7-e421220707aa
DOI
10.1101/2024.10.14.617656
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Bioprinting of Human Primary and iPSC-derived Islets with Retained and Comparable FunctionalityDOI 10.1101/2024.10.14.617656
Select a neighboring publication to make it the new centre.